BMY beat EPS expectations by 11.85%
Feb 05, 2026, 11:34 PM
0.00%
What does BMY do
Bristol Myers Squibb Co., based in Princeton, NJ, employs 34,100 staff and develops biopharmaceuticals across various therapeutic classes, including oncology and immunology. Key products include Eliquis and Opdivo, with a strong pipeline featuring Krazati and KarXT.
BristolMyers Squibb Company (BMY) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, BristolMyers Squibb Company's actual EPS was $1.26, beating the estimate of $1.13 per share, resulting in a 11.85% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.